Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
16,474,358
-
Shares change
-
+2,561,053
-
Total reported value, excl. options
-
$1,268,577,569
-
Value change
-
+$201,515,888
-
Put/Call ratio
-
33%
-
Number of buys
-
67
-
Number of sells
-
-40
-
Price
-
$77.04
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q1 2021
130 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q1 2021.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,474,358 shares
of 29,067,614 outstanding shares and own 56.68% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (2,060,132 shares), BlackRock Inc. (1,480,628 shares), LORD, ABBETT & CO. LLC (1,385,643 shares), FMR LLC (1,341,897 shares), FRAZIER MANAGEMENT LLC (895,000 shares), VANGUARD GROUP INC (830,411 shares), CREDIT SUISSE AG/ (779,380 shares), BAKER BROS. ADVISORS LP (760,412 shares), STATE STREET CORP (658,958 shares), and Farallon Capital Management, L.L.C. (625,000 shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.